Related Experiment Video
Updated: Jul 12, 2026

Growing Protein Crystals with Distinct Dimensions Using Automated Crystallization Coupled with In Situ Dynamic Light Scattering
Published on: August 14, 2018
Enabling Personalized Dose Formulation by Evaporative Crystallization Process
Nicole M Torres-Colón1, Lesly Carmona-Sarabia2,3, Aliou Mbodji2,4
1Department of Chemistry, University of Puerto Rico, Mayagüez Campus, Mayagüez, Puerto Rico, 00681, USA.
Purpose:
Evaluating a solution-based drug impregnation strategy for individualized dose formulation of warfarin sodium isopropanol (WS-IPA), a drug with a narrow therapeutic index, using microcrystalline cellulose (MCC) placebo tablets as porous carrier.
Methods:
Two formulation strategies were investigated: Add dissolved WS-IPA dropwise to a tablet, followed by solvent evaporation (M1) and dropwise addition coupled with antisolvent crystallization (M2). The tablets were characterized using powder X-ray diffraction and Raman spectroscopy for solid-form assessment. Scanning electron microscopy with energy-dispersive spectroscopy was used to visualize drug distribution and morphology. Principal component analysis was applied for Raman spectra to identify spectral differences and developed partial least squares (PLS) regression to determine WS-IPA content.
Results:
M1 resulted in amorphous WS-IPA under the conditions studied. In contrast, the antisolvent crystallization strategy (M2) promoted the formation of crystalline WS-IPA within the MCC tablets. The M2 tablets met USP dissolution requirements similar to commercial tablets (Coumadin®). External Raman PLS model validation demonstrated the potential for non-destructive WS-IPA content estimation across individualized doses, with a Root Mean Square Error of Prediction of 0.35 mg.
Conclusion:
M2 with Raman-based process analytical technology enabled crystallization control and non-destructive tablet analysis for the flexible production of individualized solid dosage forms of WS-IPA.
Related Concept Videos
Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent – the...
Recrystallization: Solid–Solution Equilibria
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Precipitation Processes

